Urology → BPH / Benign Prostate Enlargement

Benign prostate / lower urinary tract symptoms

BPH Treatment in Germany: Diagnosis, Medication, HoLEP/ThuLEP, TUR-P & Other Options

A diagnosis-first guide to benign prostatic hyperplasia in Germany, from symptom and obstruction assessment to medication, HoLEP/ThuLEP, TUR-P and selected minimally invasive procedures.

By Treat in Germany Editorial TeamSources reviewed: 2026-09-12Independent clinician review: not yet claimed
Short answer: Benign prostatic hyperplasia is not treated according to prostate size alone. German university urology programs assess symptom burden, urinary flow, residual urine, complications, prostate anatomy, PSA and the possibility of other causes of lower urinary tract symptoms before choosing treatment. Mild symptoms may be managed conservatively, medication is appropriate for many patients, and surgery or another procedure becomes more relevant when symptoms remain severe, obstruction is significant or complications such as retention, recurrent infection, bladder stones or upper-tract effects occur.

Confirm that prostate obstruction is the main problem

Lower urinary tract symptoms can come from several causes. Heidelberg describes assessment with history, examination, PSA when appropriate, ultrasound, residual urine and uroflowmetry, with pressure-flow studies used in selected cases to document outlet obstruction. A procedure should follow this assessment rather than being chosen from prostate size or marketing alone.

Treatment intensity should match symptoms and complications

Charité describes lifestyle measures for mild symptoms, medication for moderate to severe symptoms and operative treatment when symptoms remain burdensome or complications such as increasing residual urine or acute retention occur. The decision should also consider bladder function, infections, stones and kidney drainage.

Medication is a legitimate treatment pathway, not a delay before surgery

Charité and Heidelberg describe medical treatment for symptomatic BPH. Depending on the clinical situation, medicines can relax prostate and bladder-neck smooth muscle or reduce prostate growth over time. Choice and combination depend on symptom pattern, prostate characteristics, blood pressure, sexual side effects and other medication.

HoLEP and ThuLEP remove obstructing tissue endoscopically

Freiburg describes holmium- and thulium-laser enucleation for benign prostate enlargement. These procedures remove the obstructing inner prostate tissue through the urethra, allow tissue to be sent for histology and can be used across a broad range of prostate sizes in experienced centers.

TUR-P and other minimally invasive options still have roles

Heidelberg and Charité document TUR-P as an established transurethral operation, while Charité also offers other options such as GreenLight vaporization, REZUM and selected prostate-artery embolization assessment. These techniques differ in anesthesia, bleeding profile, durability, recovery, sexual side effects and whether tissue is available for pathology.

Acute urinary retention or infection with obstruction needs local care

A patient who cannot pass urine, has fever with suspected urinary obstruction, severe uncontrolled pain or acute kidney-function deterioration should be assessed promptly where they are. Planned medical travel is appropriate only after urgent problems are stabilized.

What to send for a German BPH review

A remote review is more useful when it includes objective urinary-function information rather than symptoms alone.

  • Symptom history and previous medication trials
  • Prostate volume from ultrasound or MRI if available
  • PSA history and previous biopsy information when relevant
  • Uroflowmetry and residual-urine measurements if performed
  • History of urinary retention, infection or bladder stones
  • Cystoscopy or urodynamic reports when already available
  • Current medication including anticoagulants
  • A specific question: continue medication, assess HoLEP/ThuLEP, TUR-P or another procedure

Official sources

Sources last checked 2026-09-12. Confirm current eligibility, procedure details and hospital requirements directly with the treating urology team.

Medical information notice: General educational information only; not an individual diagnosis or treatment recommendation. Acute urinary retention, fever with possible urinary obstruction, severe uncontrolled pain or acute deterioration require timely local medical assessment.
Verified centers

German centers documenting this service

These are not rankings or paid recommendations. Centers are displayed alphabetically by city and are included because their official websites document the relevant treatment, diagnostic test or specialist program. Availability for an individual patient still requires clinical review.

Charité – Urology / Benign Prostate Enlargement

Berlin · Charité documents diagnosis-first BPH care with conservative and medical treatment as well as transurethral options including ThuLEP, GreenLight vaporization, TUR-P, REZUM and selected prostate-artery embolization assessment.

University Medical Center Freiburg – Urology / BPH

Freiburg · Freiburg documents a dedicated BPH service and modern laser enucleation techniques including HoLEP and ThuLEP for symptomatic benign prostate enlargement.

Heidelberg University Hospital – Urology / BPH

Heidelberg · Heidelberg documents BPH evaluation with prostate examination, PSA when appropriate, ultrasound, residual urine and uroflowmetry, plus medical and operative treatment including established transurethral approaches.

Browse verified centers →

Connected clinical pathway

Understand the connected steps around this care

These pages connect relevant diagnosis, preparation, imaging, procedures and treatment options without implying that one finding or service automatically determines the next step. Individual sequencing requires specialist review.

Send treatment request